PUBLIC DISCLOSURE & CLARIFICATION
BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
banner
Albumin Nanoparticles
Inquiry

Albumin Nanoparticles

Inquiry
Cat. No. Product Name Inquiry
X26-06-ZQ125 Dual-functional drug-loaded nanoparticles/microspheres
X26-06-ZQ126 Drug-loaded gelatin nanoparticles
X26-06-ZQ127 Antisense oligonucleotide-loaded poly(butyl cyanoacrylate) (PBCA) nanoparticles
X26-06-ZQ128 Drug-loaded PLGA nanoparticles
X26-06-ZQ129 Drug-loaded nanoparticles
X26-06-ZQ130 Furanodiene-loaded PLGA nanoparticles
X26-06-ZQ131 Drug-loaded mesoporous silica-coated polypyrrole (PPy) nanoparticles
X26-06-ZQ132 Multifunctional drug-loaded gold nanoparticles (Au NPs)
X26-06-ZQ133 Drug-loaded silica (SiO2) nanoparticles
X26-06-ZQ134 Emodin/berberine co-loaded chitosan nanoparticles
X26-06-ZQ135 β-Elemene-loaded poly(butyl cyanoacrylate) nanoparticles
X26-06-ZQ136 Drug-loaded poly(butyl cyanoacrylate) nanoparticles
X26-06-ZQ137 Modified sodium alginate-activated SiO2 nanoparticles for stable drug loading
X26-06-ZQ138 Drug loading and controlled release performance of thermosensitive PMMA-coated hollow Fe3O4 nanoparticles
X26-06-ZQ139 Paclitaxel-loaded PCL/F68 nanoparticles
X26-06-ZQ140 Multifunctional drug-loaded polydopamine (PDA) nanoparticles
X26-06-ZQ141 Fluorescent chitosan nanoparticles
X26-06-ZQ142 Cucurbitacin-loaded polylactic acid (PLA) nanoparticles
X26-06-ZQ143 mPEG-PCL copolymer nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin (SN-38)
X26-06-ZQ144 Drug loading capacity of azithromycin nanoparticles
X26-06-ZQ145 Drug-loaded polylactic acid (PLA)-based nanoparticles
X26-06-ZQ146 Cell-penetrating peptide-modified targeted drug-loaded phase-transition nanoparticles
X26-06-ZQ147 Drug-loaded chitosan-phospholipid self-assembled nanoparticles
X26-06-ZQ148 Modified sodium alginate-activated SiO2 nanoparticles
X26-06-ZQ149 BSA drug loading performance of water-soluble chitosan nanoparticles
X26-06-ZQ150 Biotinylated perfluorocarbon nanoparticles
X26-06-ZQ151 Mesoporous silica (SiO2) nanoparticles prepared for drug loading
X26-06-ZQ152 PLGA/Chitosan bilayer drug-loaded cationic nanoparticles
X26-06-ZQ153 Mesoporous hydroxyapatite nanoparticles
X26-06-ZQ155 High drug-loading honokiol nanoparticles
X26-06-ZQ156 Magnetic graphene oxide-curcumin nanoparticles
X26-06-ZQ157 Drug-loaded albumin nanoparticles
X26-06-ZQ158 Targeted drug-loaded silk protein nanoparticles
X26-06-ZQ159 Folic acid-modified drug-loaded phase-transition nanoparticles
X26-06-ZQ160 Drug-loaded polylactic acid (PLA) nanoparticles
X26-06-ZQ161 Nimodipine/tetramethylpyrazine dual-drug-loaded nanoparticles
X26-06-ZQ162 Hyaluronic acid-modified drug-loaded Prussian blue nanoparticles
X26-06-ZQ163 Poly(aspartic acid) self-assembled nanoparticles
X26-06-ZQ164 Calcium carbonate (CaCO3)-coated polydopamine (PDA) magnetic drug-loaded nanoparticles
X26-06-ZQ165 PAMAM and upconversion nanoparticles (UCNPs)
PRODUCTS
Featured Products
Nucleic Acid Drug Delivery Products
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010) GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011) GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012) GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014) Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015) Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016) Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017) GalNAc-L96-OH (Cat#: X24-11-YM018) GalNAc-L96-TEA (Cat#: X24-11-YM019)
Hots Products
N-Glycan
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036) A2G2 N-Glycan (Cat#: X23-03-YW037) A2G2S2 N-Glycan (Cat#: X23-03-YW038) A2 N-Glycan (Cat#: X23-03-YW039) A2[6]G1 N-Glycan (Cat#: X23-03-YW040) M3 N-Glycan (Cat#: X23-03-YW041) A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
O-Glycan
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178) Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179) Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180) Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181) Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182) T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192) T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193) Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood Group and Lewis Antigen
Blood group A trisaccharide (Cat#: XCO0060Q) Blood group B trisaccharide (Cat#: XCO0068Q) Blood group H disaccharide (Cat#: XCO0074Q) Lewis A trisaccharide (Cat#: XCO0079Q) 3'-Sulfated lewis A (Cat#: XCO0080Q) Lewis B tetrasaccharide (Cat#: XCO0083Q) Lewis X trisaccharide (Cat#: XCO0085Q) Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Human Milk Oligosaccharides (HMOs)
Lacto-N-biose (Cat#: XCO0089Q) 2'-Fucosyllactose (Cat#: XCO0091Q) 3-Fucosyllactose (Cat#: XCO0092Q) Lactodifucotetraose (Cat#: XCO0093Q) Lacto-N-triose I (Cat#: XCO0094Q) 3'-Sialyllactose sodium salt (Cat#: XCO0096Q) 6'-Sialyllactose sodium salt (Cat#: XCO0098Q) 3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Glycosaminoglycans
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478) FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480) TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481) Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482) Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598) Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611) Heparin disaccharide I-A (Cat#: X22-11-ZQ662) Chondroitine sulfate (Cat#: X23-04-XQ1118)
Carbohydrate Conjugates
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007) GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008) Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037) Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038) Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039) Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
Glycolipids
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101) GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112) LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118) Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131) Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146) Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162) Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175) nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Cyclodextrin
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119) Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003) Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004) Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005) Succinyl-γ-cyclodextrin (Cat#: X23-11-B006) ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007) β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008) γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Dextran
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273) Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279) FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280) FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283) TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287) FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291) Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377) TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383) Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Important Links

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.